GE Healthcare's commitment to innovative technology has lead to the development of a non-invasive screening tool that helps transform measurement of the Nuchal Translucency (NT) with exceptional automation. Introducing Sonography-based Nuchal Translucency (SonoNTâ„¢), the first semi-automated tool to provide quantifiable NT measurements. Clinicians examining for chromosomal abnormalities in the first trimester using ultrasound can achieve the reproducible results that are crucial for diagnostic confidence. With its intuitively designed user interface, SonoNT helps users efficiently perform reliable ultrasound examinations to combine with other risk assessment tools for trisomy 21.
All Comments